Literature DB >> 8972680

Genotyping of hepatitis C virus isolates from Basque Country, Spain.

G Cilla1, M García-Bengoechea, E Perez-Trallero, I Montalvo, D Vicente, J I Arenas.   

Abstract

The genotype of HCV was determined in 161 chronic HCV-infected patients. The patients were classified into three groups on the basis of the origin of the HCV infection: 50 patients had a history of intravenous drug use (IVDU) but no HIV infection; 41 patients had received blood transfusions, and 70 patients had no known exposure. The distribution of HCV genotypes was associated with the origin of infection and age of patients: genotype 1b was predominant among patients who had received blood transfusions and those without evidence of parenteral exposure (84.6% and 67.7%, respectively), whereas genotype 3a was present in 65.3% of IVDUs. Patients with genotype 1b were older than those with genotypes 1a or 3a: 50.3 +/- 12 vs. 34.1 +/- 9.9 and 31 +/- 5.4 years, respectively. These findings suggest that the pattern of HCV genotypes in our region is changing and that genotype 1b may be substituted by 3a as the dominant genotype in the future.

Entities:  

Mesh:

Year:  1996        PMID: 8972680      PMCID: PMC2271634          DOI: 10.1017/s0950268800059227

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  29 in total

1.  A new type of hepatitis C virus in patients in Thailand.

Authors:  S Mori; N Kato; A Yagyu; T Tanaka; Y Ikeda; B Petchclai; P Chiewsilp; T Kurimura; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1992-02-28       Impact factor: 3.575

2.  Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin.

Authors:  K Stark; E Schreier; R Müller; D Wirth; G Driesel; U Bienzle
Journal:  Scand J Infect Dis       Date:  1995

Review 3.  Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis.

Authors:  Q L Choo; A J Weiner; L R Overby; G Kuo; M Houghton; D W Bradley
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

4.  [Post-transfusional hepatitis following cardiac surgery. Incidence, clinical aspects and prognosis].

Authors:  J M Barrera; M Bruguera; M G Ercilla; J M Sánchez-Tapias; J Costa; A Gelabert; R Castillo; J Rodés
Journal:  Med Clin (Barc)       Date:  1987-11-28       Impact factor: 1.725

5.  A proposed system for the nomenclature of hepatitis C viral genotypes.

Authors:  P Simmonds; A Alberti; H J Alter; F Bonino; D W Bradley; C Brechot; J T Brouwer; S W Chan; K Chayama; D S Chen
Journal:  Hepatology       Date:  1994-05       Impact factor: 17.425

6.  Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease.

Authors:  G Dusheiko; H Schmilovitz-Weiss; D Brown; F McOmish; P L Yap; S Sherlock; N McIntyre; P Simmonds
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

7.  Differences in the hepatitis C virus genotypes in different countries.

Authors:  N Takada; S Takase; A Takada; T Date
Journal:  J Hepatol       Date:  1993-03       Impact factor: 25.083

8.  Prevalence of hepatitis C virus genotypes in Italy.

Authors:  M Pistello; F Maggi; L Vatteroni; N Cecconi; F Panicucci; G P Bresci; L Gambardella; M Taddei; A Bionda; M Tuoni
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

9.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

10.  Molecular epidemiology of hepatitis C virus infection among intravenous drug users.

Authors:  E Silini; F Bono; A Cividini; A Cerino; A Maccabruni; C Tinelli; S Bruno; A Bellobuono; M Mondelli
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

View more
  1 in total

1.  Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.

Authors:  C Matheï; E Wollants; J Verbeeck; M Van Ranst; G Robaeys; P Van Damme; F Buntinx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.